
Pharmaceuticals
Developing innovative medicines for patients, creating value for healthcare providers
Developing innovative medicines for patients, creating value for healthcare providers
Pioneering evidence-based therapies, delivering better access for users
Focusing on areas of great human suffering with wider societal implications
MAY 10, 2022
One Pill Can Kill – Fentanyl Awareness Day May 10
APRIL 28, 2022
Interim Report Q1 - Promising start to 2022
APRIL 27, 2022
Orexo´s partner Gesynta Pharma granted Orphan Drug Designation by the FDA for OX-MPI - systemic sclerosis
Strong history paving the way for the future. Learn more about our key milestones since we where founded in Uppsala, Sweden, in 1995.
A week ago at ABG Sundal Collier. Gonzalo A. Castanon, Life Science analyst, is asking about the synergies with com… https://t.co/tsGcz12IfY
Sustainable companies do not only contribute to a better society, they also reduce operational risks & create long… https://t.co/5mNxAARABq
Deprexis - one of the most clinical proven #Digital therapies - can help people suffering from #depression. 🔊 Fin…https://t.co/Jt77qQgs5hh
Group net revenues
LTM1
Group EBITDA
LTM1
US Pharma segment EBIT
LTM1
Cash position
Q1 2022
1 Last Twelve Months, Q221-Q122, for more information about financial development Link